Pharmaceutical Environmental Risk Assessment

Home→ERA Profiles → Propylthiouracil→

Propylthiouracil Environmental Risk Assessment (ERA) report

Project-specific environmental risk assessment (ERA) support for human medicinal products and regulatory submissions.

CAS Registry Number
51-52-5
Molecular formula
C7H10N2OS
Molecular weight
170.23 g/mol
Drug class
Thioamide antithyroid agentThyroid hormone synthesis inhibitor
Mechanism of action
Inhibits thyroid hormone synthesis and reduces peripheral conversion of thyroxine (T4) to triiodothyronine (T3).
Indications / reported uses
  • Hyperthyroidism associated with Graves' disease or toxic multinodular goitre in patients intolerant of methimazole when surgery or radioactive iodine is not appropriate
  • Short-term control of hyperthyroidism before thyroidectomy or radioactive iodine therapy in patients intolerant of methimazole

Sources: DailyMed — Propylthiouracil tablets prescribing information

View request basketPrefer email? info@toxwriter.com
Phase IPhase II where requiredEU / UK / other markets
Assessment scope

Environmental Risk Assessment (ERA)

ToxWriter provides project-specific support for the Propylthiouracil Environmental Risk Assessment (ERA) (the Propylthiouracil ERA report). The required pathway is determined by the medicinal product, active-substance form, route, intended market, use assumptions and available environmental evidence.

Assessment may cover

  • Product, active-substance identity, formulation, route and intended-market review.
  • Phase I environmental exposure screening and applicable trigger evaluation.
  • Phase II environmental fate and ecotoxicity assessment where required by the applicable pathway.
  • PEC/PNEC risk characterisation and PBT/vPvB considerations where relevant and supported by evidence.
  • Data-gap analysis, study strategy, assumptions and scientific reporting.
ERA regulatory framework

The EMA guideline sets out the EU framework for environmental risk assessment of human medicinal products. MHRA guidance describes UK expectations; the applicable scope depends on the product and submission context.